While several studies have revealed XPOT overexpression in mesothelioma, leukemia HL-60 cells, and hepatocellular carcinoma 20-23, the exact molecular mechanisms of XPOT in these tumors remain elusive, especially whether and how XPOT modulates tumor progression through tRNA nuclear export. This evidence concerns the gene XPOT and hepatocellular carcinoma.